Financial comparisons Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 184.04 USD | -0.34% |
|
+2.85% | -0.30% |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
 | 4.05B | 0.25% | 19.9% | 15.1% | 6.78% | 2.05x | |
| 7.25B | 9.67% | 17.9% | 6.77% | 3.48% | 1.5x | |
| 15.4B | 8.91% | 20.12% | 33.53% | 5.12% | 3.33x | |
| 3.81B | -16.92% | -14.91% | -17.71% | -11.1% | 4.46x | |
| 2.41B | 11.88% | 13.83% | 2.46% | 2.14% | 1.28x | |
| 2.11B | 19.17% | 21.38% | 58.42% | 21.52% | -1.39x | |
| 8.28B | 9.56% | 19.29% | 12.39% | 6.87% | 1.66x | |
| 693M | -107.63% | -20.47% | - | -25.37% | 0.13x | |
| 705M | -64.4% | -67.38% | -93.12% | -15.15% | 2.26x | |
| 376M | -103.97% | -76.66% | - | -37.71% | -1.14x | |
| 7.2B | 5.84% | 14.63% | 7.8% | 3.73% | 1.93x | |
| 1.98B | 4.23% | 28.66% | 13.31% | 8.32% | 0.34x | |
| 1.22B | 6.02% | 31.45% | 15.37% | 11.65% | 0.43x | |
| 12.94M | -1,409.6% | -1,383.2% | -148.95% | - | 0.4x | |
| 509M | -13.19% | -41.67% | -31.26% | -21.6% | -0.14x | |
| 1.68B | 14.61% | 17.14% | 13.7% | 7.12% | 1.33x | |
| 905M | 6.14% | 7.92% | 1.94% | 1.39% | 0.27x | |
| Average | 3.45B | -95.26% | -81.89% | -7.35% | -2.05% | 1.10x | |
| Weighted average by Cap. | 5.17B | -49.34% | -37.72% | 0.07% | -1.27% | 1.66x |
- Stock Market
- Equities
- CRL Stock
- Sector Charles River Laboratories International, Inc.
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition